ESMO20 YO for YO: highlights on oncogene-addicted NSCLC.
作者信息
Lim K H J, Gomes F
机构信息
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK.
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
出版信息
ESMO Open. 2021 Feb;6(1):100026. doi: 10.1016/j.esmoop.2020.100026. Epub 2020 Dec 31.
Abstract
摘要
相似文献
1
ESMO20 YO for YO: highlights on oncogene-addicted NSCLC.针对年轻患者的欧洲肿瘤内科学会（ESMO）20 年：成瘾性致癌基因非小细胞肺癌的亮点
ESMO Open. 2021 Feb;6(1):100026. doi: 10.1016/j.esmoop.2020.100026. Epub 2020 Dec 31.
2
ESMO20 YO for YO: highlights on metastatic NSCLC-Keynote 024 update.ESMO 20年随访20年：转移性非小细胞肺癌的要点——KEYNOTE-024更新
ESMO Open. 2021 Feb;6(1):100022. doi: 10.1016/j.esmoop.2020.100022. Epub 2021 Jan 4.
3
European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient.欧洲医学肿瘤学会（ESMO）关于癌基因成瘾性转移性非小细胞肺癌（NSCLC）的指南：针对每位患者的个性化治疗。
Chin Clin Oncol. 2024 Jun;13(3):46. doi: 10.21037/cco-23-100. Epub 2024 Feb 20.
4
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?非成瘾性非小细胞肺癌脑转移的治疗策略：走向光明的未来？
Crit Rev Oncol Hematol. 2018 Aug;128:19-29. doi: 10.1016/j.critrevonc.2018.05.013. Epub 2018 May 24.
5
Acquired resistance in oncogene-addicted non-small-cell lung cancer.癌基因成瘾性非小细胞肺癌的获得性耐药。
Future Oncol. 2018 Jun;14(13s):29-40. doi: 10.2217/fon-2018-0097.
6
Personalized targeted therapy in advanced non-small cell lung cancer.晚期非小细胞肺癌的个体化靶向治疗。
Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS56-60. doi: 10.3949/ccjm.79.s2.12.
7
BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?BRAF突变——对于癌基因成瘾性非小细胞肺癌中免疫检查点抑制剂来说是个好消息？
J Thorac Oncol. 2018 Aug;13(8):1055-1057. doi: 10.1016/j.jtho.2018.06.002. Epub 2018 Jul 2.
8
EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospects.表皮生长因子受体突变型致癌基因成瘾型非小细胞肺癌：当前趋势与未来展望。
Cancer Treat Rev. 2012 Aug;38(5):416-30. doi: 10.1016/j.ctrv.2011.10.003. Epub 2011 Nov 25.
9
Oncogene addicted non-small-cell lung cancer: current standard and hot topics.癌基因成瘾型非小细胞肺癌：当前标准和热点话题。
Future Oncol. 2018 Jun;14(13s):3-17. doi: 10.2217/fon-2018-0095.
10
Optimising therapy for EGFR-addicted NSCLC: just the start.优化针对EGFR依赖型非小细胞肺癌的治疗：这只是开始。
Lancet Oncol. 2012 Mar;13(3):216-7. doi: 10.1016/S1470-2045(12)70037-2. Epub 2012 Jan 26.
Zotero 插件